Research Reports

Healthcare

icon
Home » Reports » Wearable Cardioverter Defibrillator Market
Market Research Report

Wearable Cardioverter Defibrillators Market By Condition (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias); By Product (Implantable Cardioverter Defibrillators (ICDS), External defibrillators); By End-User (Hospitals, Home Care Settings, Clinics) - Global Demand Analysis & Opportunity Outlook 2027

Published On : 07:20 AM, 13th July, 2018 REP-ID-874 Category: Healthcare

Wearable Cardioverter Defibrillators Market Overview

Wearable cardioverter defibrillators are used to prevent the incidence of heart attacks. These are external devices that are non-penetrating. Heart attacks occur when there is problem with the heart's electrical system. The heart relaxes and contracts on the guidance of this electrical system. State when there is irregular tempo in the ventricles of the heart is called Ventricular Fibrillation. If VF (Ventricular Fibrillation) occurs, an electrical current is sent to the heart by the defibrillator which is used to re-start a normal heart pulsation. Defibrillators are used for the treatment of deadly heart dysrhythmias, ventricular tachycardia and ventricular fibrillation. They regulate irregular heartbeat, treat patients affected by sudden heart failure and prevent heart failures. Defibrillators can be inside the body (internal) or outside the body (external). The wearable defibrillator is a treatment given to patients who are at higher risks of abrupt heart seizures or sudden cardiac death.

Market Size & Forecast

Wearable cardioverter defibrillator market is anticipated to record a significant CAGR over the forecast period. The wearable cardioverter defibrillator market is witnessing a rapid evolving technology situation, leading to development of innovative products. The occurrence of cardiovascular diseases has augmented in individuals below 35 years. Among cardiovascular disorders, SCA (Sudden Cardiac Arrest) is one of the major causes of death in younger population. Increasing awareness about the disease and rising demand for treatment of SCA is estimated to increase the demand in the market.

Wearable cardioverter defibrillator is exercised for the conditions like Peripartum Cardiomyopathy, Inherited Arrhythmias and Congenital heart diseases. The market is pushed by some key factors such as launch of rental services for wearable cardioverter defibrillators for the patients, reducing the rate and making it reasonable in developing countries, boosting patient education and training, future development in technology will help in introducing patient friendly devices by decreasing the size and weight of the defibrillators.

On the basis of regional platform, global wearable cardioverter defibrillator market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North American industries consists of the largest market shares and are likely to rule this business sector due to growing occurrence of cardiac diseases, prolonged growth and development in healthcare industry. USA and Canada contribute to the overall defibrillator market in the region. Europe has the second largest market share in the industry.

Wearable Cardioverter Defibrillators Market Size

In Asia-Pacific and Middle East regions more workstations and business environments are introducing developments in defibrillators. The Market is estimated to be driven by increase in demand which will benefit the market in upcoming years. Incredible growth prospects are observed in this region due to increasing awareness and availability of these devices.

Market Segmentation

Our-in depth analysis of the global wearable cardioverter defibrillators market includes the following segments:

By Condition

  • Peripartum Cardiomyopathy
  • Congenital Heart Disease
  • Inherited Arrhythmias

By Product

  • Implantable Cardioverter Defibrillators (ICDS)
    • Subcutaneous Implantable Cardioverter Defibrillators(S-ICDS)
    • Trans-venous Implantable Cardioverter Defibrillators (T-ICDS)
  • External defibrillators
    • Automated External Defibrillators (AEDS)
    • Manual External Defibrillators

By End-User

  • Hospitals
  • Home Care Settings
  • Cardiology Clinics

By Region

Global wearable cardioverter defibrillators market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Wearable Cardioverter Defibrillators Market Share

Growth Drivers & Challenges

Rising incidences of cardiovascular disorders across the world is a key dynamic propelling the growth of wearable cardioverter defibrillators market. Wearable cardioverter defibrillators have become gradually and widely accepted, as this device can be employed in a condition where a patient is waiting for an implantable one owing to surgical contraindication and this device prevents the risk of cardiac arrest. The device can be used by patient with recent myocardial infarction and left ventricular dysfunction, in an event where there is no firm indication for installing implantable devices. Apart from these numerous technological advances in the devices scheduled to happen in future for instance decreasing the weight and size further to make it more comfortable for the patient, improvement in signal to reduce the event of inappropriate detections and shocks and reduction in electrode noise will contribute to the wearable cardioverter defibrillators market expansion.

Conversely, factors such as insufficient trained staff and expert technicians, uncertainty to use the device due to safety issues among patient group coupled with limitations faced by the devices such as lack of provision to monitor atrial arrhythmias may obstruct the estimated wearable cardioverter defibrillators market growth during the forecast period.

Key Players

  • ZOLL Medical Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Medtronic
  • St. Jude Medical LLC
  • Boston Scientific Corporation
  • LivaNova
  • Koninklijke Philips N.V.
  • Cardiac Science
  • Physio-Control Inc.
  • Nihon Kohden Corporation
  • Defibtech LLC

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Wearable Cardio Defibrillators Market is segmented as follows:

  • By Condition Type Market Size & Y-O-Y Growth Analysis
  • By Product Type Market Size & Y-O-Y Growth Analysis
  • By End-User Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top